Klinik für Pädiatrische Rheumatologie und Immunologie

Hospach T, Haas G, Huppertz HI, Keitzer R, Michels H, Trauzeddl R,  Foell D,  Dannecker G, Horneff G. Stellungnahme der Gesellschaft für Kinder- und Jugendrheumatologie zur Meldung der US- Food and Drug Administration (FDA) über Fälle von Malignomen bei Anti-TNF behandelten Patienten. Z Rheumatol 2009;68:162-4.

Van Zoelen MAD, Vogl T, Foell D, Van Veen SQ, van Till JWO, Florquin S, Tanck MW, Wittebole X, Laterre P, Boermeester MA, Roth J, van der Poll T. Expression and role of myeloid-related protein-14 in clinical and experimental sepsis. Am J Resp Crit Care Med 2009;180:1098-106.

Langhorst J, Wieder A, Rueffer A, Wehkamp J, Foell D, Michalsen A, Musial F, Dobos GJ. Activated innate immune system in irritable bowel syndrome? Am J Gastroenterol 2009;104(2):404-10.

Lenz P, Wessling J, Foell D, Nowacki T, Ullerich H, Domschke W, Domagk D. Incomplete Tubular Duplication of the Esophagus Becoming Symptomatic in Adulthood. Endoscopy 2009;41 Suppl 2:E114-5.

Hirono K, Kemmotsu Y, Wittkowski H, Foell D, Saito K, Ibuki K, Watanabe K, Watanabe S, Uese K, Kanegane H, Origasa H, Ichida F, Roth J, Miyawaki T, Saji T. Infliximab reduces the cytokine-mediated inflammation but does not suppress cellular infiltration of the vessel wall in refractory Kawasaki disease. Pediatr Res 2009;65(6):696-701.

Eisenblätter M, Ehrchen J, Varga G, Sunderkötter C, Heindel W, Roth J, Bremer C, and Wall A. In Vivo Optical Imaging of Cellular Inflammatory Response in Granuloma Formation Using Fluorescence-Labeled Macrophages. J Nucl Med. 2009: Vol. 50; p. 1676-1682

Oreshkova T, Wang H, Seier A, Sindrilaru A, Varga G, Grabbe S, Scharfetter Kochanek K, and Peters T. Beta2-integrin deficiency yields unconventional DN T cells distinct from mature classical NKT cells in mice. Immunology. 2009: Vol. 128; p. 271-286

Ahlmann M, Varga G, Sturm K, Lippe R, Benedyk K, Viemann D, Scholzen T, Ehrchen J, Mueller FU, Seidl M, Matus M, Tsokos GC, Roth J, and Tenbrock K. The Cyclic AMP Response Element Modulator alpha (CREMalpha suppresses CD86 expression and APC function. J. Immunol. 2009: Vol. 182; p. 4167-4174

Ehrchen JM, Sunderkötter C, Foell D, Vogl T, Roth J. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol 2009 Sep;86(3):557-66. Hirono K, Kemmotsu Y, Wittkowski H, Foell D, Saito K, Ibuki K, Watanabe K, Watanabe S, Uese K, Kanegane H, Origasa H, Ichida F, Roth J, Miyawaki T, Saji T. Infliximab reduces the cytokine-mediated inflammation but does not suppress cellular infiltration of the vessel wall in refractory Kawasaki disease. Pediatr Res. 2009 Jun;65(6):696-701.

Foell D, Wittkowski H, Roth J. Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage. Gut. 2009 Jun;58(6):859-68.

Lachmann HJ, Lowe P, Felix SD, Rordorf C, Leslie K, Madhoo S, Wittkowski H, Bek S, Hartmann N, Bosset S, Hawkins PN, Jung T. In vivo regulation of interleukin 1beta in patients with cryopyrin-associated periodic syndromes. J Exp Med. 2009 May 11;206(5):1029-36.

Moroz OV, Burkitt W, Wittkowski H, He W, Ianoul A, Novitskaya V, Xie J, Polyakova O, Lednev IK, Shekhtman A, Derrick PJ, Bjoerk P, Foell D, Bronstein IB. Both Ca2+ and Zn2+ are essential for S100A12 protein oligomerization and function. BMC Biochem. 2009 Apr 23;10:11.

Frosch M, Ahlmann M, Vogl T, Wittkowski H, Wulffraat N, Foell D, Roth J. The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2009 Mar;60(3):883-91.

Kessel C, Kreuz W, Klich K, Becker-Peters K, Vorpahl F, Dietrich U, Klingebiel T and Königs C. Multimerisation of peptide mimotopes for blocking of factor VIII neutralizing antibodies. ChemMedChem 4, 2009; 1364-70.